Casi un centenar de centros sanitarios andaluces colaboran con la industria farmacéutica en ensayos clínicos

by Farmaindustria

​En la última década, 92 centros sanitarios andaluces, tanto públicos como privados, han colaborado con la industria farmacéutica innovadora en el desarrollo de 2.413 ensayos clínicos, en los q...

Read more

Oryzon nominates ORY-3001, a specific LSD1 inhibitor, next drug candidate to enter preclinical development in non-oncological indications

by Oryzon Genomics

Oryzon Genomics (ISIN Code: ES0167733015 , ORY ), a public clinical - stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced ...

Read more

From the Antarctic Sea to the SaaS platform

by Mind the Byte

So far, this group of experts from the UB and IRBio have discovered bioactive molecules like hodgsonal, terpenoid acylglycerols, glassponsine, granuloside, illudalanes, triterpene glycosides, and some...

Read more

Maps show how drugs reverse alterations in hepatitis C-infected cells

by Centro Nacional de Biotecnología (CNB)

Researchers at the Centro Nacional de Biotecnología of the CSIC (CNB-CSIC) and the ALBA Synchrotron have now looked inside an infected cell in three dimensions and seen how the virus greatly distorts...

Read more

Launch of Nostrum BioDiscovery, a spin-off that applies supercomputing to speed up drug discovery

by IRB Barcelona - Instituto de Investigación Biomédica

Nostrum BioDiscovery has come about from the combined efforts of IRB Barcelona and the BSC-CNS—two research centres of excellence in Barcelona—with the participation of the University of Barcelona...

Read more

Avizorex Pharma submits Clinical Trial Application for its lead compound AVX-012 for Dry Eye Syndrome

by Parc Científic de Barcelona

Avizorex Pharma –an ophthalmology biotech company with offices at Barcelona Science Park (PCB)– announcesthe submission of a Clinical Trial Application (CTA) to the Spanish Competent Authority, re...

Read more

Takeda and TiGenix enter into licensing agreement for Ex-U.S. rights to Cx601 for the treatment of complex perianal fistulas in patients with crohn’s disease

by TIGENIX SAU

​Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels: TIG) (“TiGenix”) today announced that the companies have entered into an exclusive ex-U.S. li...

Read more

EntreChem reports a ketone reduction – nitrile hydrolysis cascade for chiral hydroxiacids

by EntreChem

The results, part of the EU Training Network BIOCASCADES, highlight the opportunities offered by developing multi-step processeses in a cascade fashion. This kind of all-enzymatic cascade, performed i...

Read more

El Ministerio de Economía y FARMAINDUSTRIA buscan oportunidades compartidas en el ámbito de la I+D+i

by Farmaindustria

Fortalecer la colaboración público-privada en la investigación de excelencia. El Ministerio de Economía, Innovación y Competitividad, a través de la Secretaría de Estado de Investigación, Desa...

Read more

Barcelona quiere captar la Agencia Europea del Medicamento después del Brexit

by Biocat

La Generalitat impulsa una comisión para que la sede se traslade de Londres a la capital catalana y recibe el apoyo del Gobierno español

Read more

El IMIM participa en el primer gran ensayo de código abierto de descubrimiento de fármacos

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

La prestigiosa revista PLoS Pathogens acaba de publicar un artículo sobre los resultados del proyecto Malaria Box, una iniciativa de Medicine for Malaria Venture que ha facilitado el acceso abierto a...

Read more

Takeda and TiGenix Announce the Results of the Phase 3 ADMIRE-CD Trial Investigating Cx601 in the Treatment of Complex Perianal Fistulas in Patients with Crohn’s Disease

by TIGENIX SAU

Takeda and TiGenix Announce Publication in The Lancet of 24-Week Results of the Phase 3 ADMIRE-CD Trial Investigating Cx601 in the Treatment of Complex Perianal Fistulas in Patients with Crohn’s Dis...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream